
CAS 1820817-64-8
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produits concernés.
Methanesulfonato{[4-(N,N-dimethylamino)phenyl]di-t-butylphosphino}(2'-amino-1,1'-biphenyl-2-yl)palladium(II), min. 98% [Amphos Palladacycle Gen. 3]
CAS :<p>Methanesulfonato{[4-(N,N-dimethylamino)phenyl]di-t-butylphosphino}(2'-amino-1,1'-biphenyl-2-yl)palladium(II), min. 98% [Amphos Palladacycle Gen. 3]</p>Formule :C29H41N2O3PPdSDegré de pureté :min. 98%Couleur et forme :beige to tan pwdr.Masse moléculaire :635.11Methanesulfonato{[4-(N,N-dimethylamino)phenyl]di-t-butylphosphino}(2'-amino-1,1'-biphenyl-2-yl)palladium(II), min. 98% [Amphos Palladacycle Gen. 3]
CAS :Formule :C29H41N2O3PPdSDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :635.1062Ref: IN-DA01FR0N
1g146,00€5g499,00€10g520,00€25gÀ demander50gÀ demander100gÀ demander100mg50,00€250mg69,00€Methanesulfonato{[4-(N,N-DimethylAmino)Phenyl]di-t-Butylphosphino}(2-Amino-1,1-biPhenyl-2-yl)Palladium(II)
CAS :Methanesulfonato{[4-(N,N-DimethylAmino)Phenyl]di-t-Butylphosphino}(2-Amino-1,1-biPhenyl-2-yl)Palladium(II)Degré de pureté :98%Masse moléculaire :635.11g/molAPhos Pd G3
CAS :<p>APhos Pd G3 is a drug with a bicyclic structure. It is an inhibitor of ganglion cells and has been shown to have a positive effect on the symptoms of dementia, psychosis, and psychiatric disorders. It has also been shown to be beneficial in the treatment of Parkinson's disease, which is characterized by the loss of dopaminergic neurons. APhos Pd G3 prevents neuronal cell death by inhibiting monoamine oxidase-B (MAO-B), which breaks down dopamine. This leads to increased levels of dopamine in the striatum and improved motor function. APhos Pd G3 also blocks MAO-A, which breaks down serotonin, norepinephrine, and epinephrine. The inhibition of MAO-A leads to increased levels of serotonin and norepinephrine in the brainstem and spinal cord.</p>Formule :C29H41N2O3PPdSDegré de pureté :Min. 95%Masse moléculaire :635.11 g/mol





